Skip to main content
Clinical Trials/JPRN-UMIN000013660
JPRN-UMIN000013660
Completed
Phase 4

Evaluation of the diagnosis accuracy and eradication protocol of Helicobacter pylori gastritis in CKD 5 hemodialysis patients - The diagnosis and eradication of Helicobacter pylori in CKD

Division of Clinical Nephrology & Rheumatology, Niigata University Graduate School of Medical & Dental Sciences0 sites30 target enrollmentApril 8, 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hemodialysis patients with Helicobacter pylori gastritis
Sponsor
Division of Clinical Nephrology & Rheumatology, Niigata University Graduate School of Medical & Dental Sciences
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2014
End Date
December 31, 2014
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Division of Clinical Nephrology & Rheumatology, Niigata University Graduate School of Medical & Dental Sciences

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with a history of hypersensitivity for amoxicillin, clarithromycin, proton pump inhibitors, or metronidazole. 2\) Of the patients with CKD, the patient being predicted for initiating dialysis within six months. 3\) Patients complicated with acute inflammatory disease or active infection. 4\) Patients with active malignant tumor. 5\) Patients who suspected of being pregnant or pregnancy. 6\) Patients did not make a consent for test and/or treatment of H. pyroli gastritis. 7\) Patients was determined to be difficult to continue the eradication therapy by serious adverse events. 8\) Patients offer discontinuation of the study. 9\) Attending physician deems the patients as unsuitable of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials